See more
At EY, our purpose is building a better working world. The insights and services we provide help to create long-term value for clients, people and society, and to build trust in the capital markets.
See more
Press release
07 Oct 2026Barbara Dimajo
Press release
30 Sep 2026Barbara Dimajo
Press release
Vellayan Subbiah from India named EY World Entrepreneur Of The Year™ 2024
07 Jun 2024Eric J. Minuskin
Press release
09 Apr 2024Michael Curtis
Press release
EY announces acceleration of client AI Business Model adoption with NVIDIA AI
20 Mar 2024Barbara Dimajo
Recent Searches
Trending
How the global IPO market proved its resilience in Q3
The EY Global IPO Trends Q3 2026 highlights the market’s resilience as sector participation broadens amid ongoing geopolitical and economic challenges.
13 Oct 2026 IPO
A supply chain solution sparked an industry-leading reaction for DuPont
EY creates a supply chain solution to position this chemicals company with one of the most resilient supply chains on the planet. Read the case study.
01 Nov 2022 Supply-chain
ey.ai The Reimagination Engine
ey.ai The Reimagination Engine helps organizations to scale AI across the enterprise, delivering trusted intelligence, connected capabilities and real business value.
16 Nov 2023 AIEY Global Life Sciences Leader; EY EMEIA Life Sciences Market Lead
Passionate about driving health outcomes. Focused on making pharmaceutical innovations affordable and easily accessible to everyone.
As EY Global and EMEIA Life Sciences Sector Lead, Daniel is passionate about helping life sciences companies deliver better patient outcomes in the most efficient and effective way that can mutually benefit firms, payors, providers and patients.
Daniel started his career at a major pharmaceutical company and later in the NHS (National Health Service). Within pharma, Daniel managed the integration of the Welcome acquisition into Europe; implemented the UK pharmacy-agency distribution model, an industry first; managed a healthcare venture fund which sought to create physician-led companies; and then lead the sales and marketing for the European Neurology franchise. Within the NHS, Daniel created the first commercial clinical Site Management Organization that used the NHS’s unique data set to accelerate access to clinical trials.
Daniel earned a BSc (1st Hons) in Geography from the University of Bristol and an MSc in Computer and Information Science.
“Every day in the life sciences sector, I am able to see many opportunities to help build a better working world. Our challenge, however, is making sure that we focus our efforts on the transformational projects that will enable the greatest number of patients to gain access to the right treatments.”